The current stock price of SXTC is 2.55 USD. In the past month the price decreased by -87.77%. In the past year, price decreased by -99.4%.
ChartMill assigns a fundamental rating of 2 / 10 to SXTC. The financial health of SXTC is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months SXTC reported a non-GAAP Earnings per Share(EPS) of -3.01. The EPS increased by 97.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.25% | ||
| ROE | -21.4% | ||
| Debt/Equity | 0.05 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 30.53 | 987.61B | ||
| JNJ | JOHNSON & JOHNSON | 20.46 | 574.955B | ||
| MRK | MERCK & CO. INC. | 21.65 | 292.01B | ||
| PFE | PFIZER INC | 9.19 | 153.798B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 10 | 123.713B | ||
| ZTS | ZOETIS INC | 18.66 | 56.1B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.52 | 25.427B | ||
| VTRS | VIATRIS INC | 6.31 | 17.921B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.5 | 12.337B | ||
| AXSM | AXSOME THERAPEUTICS INC | 225.04 | 9.236B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.
CHINA SXT PHARMACEUTICALS IN
178 Taidong Road North
Taizhou JIANGSU 225300 CN
CEO: Feng Zhou
Employees: 75
Phone: 8652386298290
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.
The current stock price of SXTC is 2.55 USD. The price decreased by -7.94% in the last trading session.
SXTC does not pay a dividend.
SXTC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
The outstanding short interest for CHINA SXT PHARMACEUTICALS IN (SXTC) is 4.54% of its float.